Fund Holdings — Prosight Management, LP

Total Portfolio Value:
$304.34M
Total Bought:
$55.95M
Total Sold:
$77.54M
Net Transaction:
-$21.58M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Lakefront Biotherapeutics NVADR(LKFT)1,025,0001,314,898+289,898$28.19M$33.03M10.85%+$4.84M
MeiraGTx Holdings plc(MGTX)4,390,8373,691,546-699,291$26.74M$25.03M8.22%-$1.71M
BridgeBio Pharma, Inc.(BBIO)995,000610,000-385,000$27.30M$21.09M6.93%-$6.22M
Janux Therapeutics, Inc.(JANX)329,768689,901+360,133$17.66M$18.63M6.12%+$971.5K
Roivant Sciences Ltd.SHS(ROIV)1,500,0001,826,163+326,163$17.75M$18.43M6.05%+$681.0K
Mirum Pharmaceuticals, Inc.(MIRM)451,127343,326-107,801$18.65M$15.47M5.08%-$3.19M
Kura Oncology, Inc.(KURA)1,325,0002,078,315+753,315$11.54M$13.72M4.51%+$2.18M
ADC Therapeutics SASHS(ADCT)9,515,0009,543,004+28,004$18.93M$13.46M4.42%-$5.48M
Zymeworks Inc.(ZYME)820,000957,229+137,229$12.00M$11.40M3.75%-$604.2K
Amicus Therapeutics Inc
COM
920,0001,379,383+459,383$8.67M$11.26M3.70%+$2.59M
ICON Public Limited CompanySHS(ICLR)85,00060,099-24,901$17.83M$10.52M3.46%-$7.31M
Rocket Pharmaceuticals, Inc.(RCKT)1,088,7061,480,000+391,294$13.69M$9.87M3.24%-$3.81M
Acadia Healthcare Company, Inc.(ACHC)692,000290,000-402,000$27.44M$8.79M2.89%-$18.64M
argenx SEADR(ARGX)013,700+13,700$0$8.11M2.66%+$8.11M
Schrödinger, Inc.(SDGR)720,500385,000-335,500$13.90M$7.60M2.50%-$6.30M
Syndax Pharmaceuticals, Inc.(SNDX)620,000609,252-10,748$8.20M$7.48M2.46%-$711.7K
Tectonic Therapeutic, Inc.(TECX)0398,885+398,885$0$7.06M2.32%+$7.06M
Intuitive Surgical, Inc.(ISRG)014,000+14,000$0$6.93M2.28%+$6.93M
Shattuck Labs, Inc.(STTK)6,638,9356,638,9350$8.03M$6.31M2.07%-$1.73M
AbCellera Biologics Inc.(ABCL)7,350,0002,815,652-4,534,348$21.54M$6.28M2.06%-$15.26M
Immunovant, Inc.(IMVT)305,523360,000+54,477$7.57M$6.15M2.02%-$1.42M
Prothena Corp PlcSHS
SHS
418,122408,122-10,000$5.79M$5.05M1.66%-$740.5K
LivaNova PLCSHS(LIVN)70,000127,300+57,300$3.24M$5.00M1.64%+$1.76M
Haemonetics Corporation(HAE)46,70065,400+18,700$3.65M$4.16M1.37%+$509.8K
Blueprint Medicines Corp67,00036,512-30,488$5.84M$3.23M1.06%-$2.61M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)270,000575,136+305,136$3.19M$3.05M1.00%-$132.0K
CytomX Therapeutics, Inc.(CTMX)3,905,0003,930,008+25,008$4.02M$2.50M0.82%-$1.52M
CareDx, Inc.(CDNA)80,000136,593+56,593$1.71M$2.42M0.80%+$711.7K
Biohaven Ltd.(BHVN)0100,000+100,000$0$2.40M0.79%+$2.40M
Addus Homecare Corp024,045+24,045$0$2.38M0.78%+$2.38M
Sight Sciences, Inc.(SGHT)908,847969,287+60,440$3.31M$2.33M0.76%-$981.9K
Erasca, Inc.(ERAS)947,110947,1100$2.38M$1.30M0.43%-$1.08M
Spyre Therapeutics, Inc.(SYRE)80,00074,921-5,079$1.86M$1.21M0.40%-$653.5K
OnKure Therapeutics, Inc.CL A(OKUR)63,754186,570+122,816$548.3K$802.3K0.26%+$254.0K
Rein Therapeutics Inc.(RNTX)404,979430,000+25,021$931.5K$761.1K0.25%-$170.4K
Mural Oncology Pub Ltd Co466,822422,743-44,079$1.50M$532.7K0.18%-$970.5K
Pliant Therapeutics, Inc.(PLRX)0334,263+334,263$0$451.3K0.15%+$451.3K
Immunome, Inc.(IMNM)54,34223,618-30,724$577.1K$158.9K0.05%-$418.2K
Centene Corporation(CNC)55,0000-55,000$3.33M$0—-$3.33M
Fortrea Holdings Inc.(FTRE)55,1000-55,100$1.03M$0—-$1.03M
Zimmer Biomet Holdings, Inc.(ZBH)80,0000-80,000$8.45M$0—-$8.45M
Page 1 of 1
Prosight Management, LP — 13F Holdings — Q1 2025 | TickerTrail